
Aug 13, 2025, 05:29
George Kumar: How Discovery of Monoclonal Antibodies Transformed Biomedical Science and Health Care
George Kumar, Senior Director at AstraZeneca, shared on LinkedIn:
“Fifty years ago, the discovery of monoclonal antibodies transformed biomedical science and health care.
This breakthrough not only paved the way for life-changing treatments but also stands as a powerful reminder of how open collaboration and the free exchange of ideas can drive innovation that changes lives.”
More posts featuring George Kumar on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 13, 2025, 13:21
Aug 13, 2025, 12:52
Aug 13, 2025, 12:45